Caffeine reduces dipyridamole-induced myocardial ischemia.
The mechanism of action of coronary vasodilation after dipyridamole may be based on inhibition of cellular uptake of circulating endogenous adenosine. Since caffeine has been reported to be a competitive antagonist of adenosine we studied the effect of caffeine on the outcome of dipiridamole-201Tl cardiac imaging in one patient. During caffeine abstinence dipyridamole induced myocardial ischemia with down-slope ST depressions on the ECG, and reversible perfusion defects on the scintigrams. When the test was repeated 1 wk later on similar conditions, but now shortly after infusion of caffeine (4 mg/kg), the ECG showed no, and the scintigrams only slight signs of ischemia. We conclude that when caffeine abstinence is not sufficient, the widespread use of coffee and related products may be responsible for false-negative findings in dipyridamole-201Tl cardiac imaging.
Smits
P
P
Department of Internal Medicine, St. Radboud Hospital, University of Nijmegen, The Netherlands.
Aengevaeren
W R
WR
Corstens
F H
FH
Thien
T
T
D002110:Caffeine / Q000097:blood / Q000627:therapeutic use*; D003327:Coronary Disease / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004176:Dipyridamole / Q000009:adverse effects*; D004562:Electrocardiography; D006321:Heart / Q000000981:diagnostic imaging / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D013794:Thallium Radioisotopes
D013794:Thallium Radioisotopes; D002110:Caffeine; D004176:Dipyridamole